Back
Mesa Laboratories Vs. Ultragenyx Pharmaceutical Industry Stock Comparison
Buy
54
MLAB
Mesa Laboratories
Last Price:
128.98
Seasonality Move:
3.99%
Sell
49
RARE
Ultragenyx Pharmaceutical
Last Price:
58.74
Seasonality Move:
-0.7%
Buy
54
Mesa Laboratories (MLAB)
is a Buy
Is Mesa Laboratories a Buy, Sell or Hold?
- The current Mesa Laboratories [MLAB] share price is $128.43. The Score for MLAB is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- MLAB is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
49
Ultragenyx Pharmaceutical (RARE)
is a Sell
Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?
- The current Ultragenyx Pharmaceutical [RARE] share price is $58.77. The Score for RARE is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
- RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MLAB Stock Price Chart
What is Mesa Laboratories's stock price today?
-
The Mesa Laboratories share price today is $128.43
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and MLAB is experiencing slight buying pressure.
RARE Stock Price Chart
What is Ultragenyx Pharmaceutical's stock price today?
-
The Ultragenyx Pharmaceutical share price today is $58.77
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RARE is experiencing slight selling pressure.
MLAB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.9 | Buy |
| Relative Strength Index (14 RSI): | 56.5 | Buy |
| Chaikin Money Flow: | 7696 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (121.07 - 133.79) | Buy |
| Bollinger Bands (100): | (98.02 - 125.28) | Buy |
RARE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.9 | Buy |
| Relative Strength Index (14 RSI): | 65.66 | Buy |
| Chaikin Money Flow: | -154927 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (54.53 - 58.27) | Buy |
| Bollinger Bands (100): | (39.73 - 52.87) | Buy |
MLAB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 123.22 | Buy |
| 20-day SMA: | 126.85 | Buy |
| 50-day SMA: | 119.87 | Buy |
| 200-day SMA: | 106.75 | Buy |
| 8-day EMA: | 124.67 | Buy |
| 20-day EMA: | 124.37 | Buy |
| 50-day EMA: | 119.73 | Buy |
| 200-day EMA: | 113.21 | Buy |
RARE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 57.87 | Buy |
| 20-day SMA: | 57.08 | Buy |
| 50-day SMA: | 51.49 | Buy |
| 200-day SMA: | 46.42 | Buy |
| 8-day EMA: | 57.94 | Buy |
| 20-day EMA: | 56.47 | Buy |
| 50-day EMA: | 52.53 | Buy |
| 200-day EMA: | 46.74 | Buy |
Mesa Laboratories Earnings Growth & MLAB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.29 per share, an increase next quarter of $0.22 per share, an increase this year of $0.71 per share, and a decrease next year of $0.52 per share.
Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.53 per share, an increase next quarter of $0.18 per share, an increase this year of $1.07 per share, and an increase next year of $1.02 per share.
Mesa Laboratories Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ultragenyx Pharmaceutical Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||